Alzheimer’s Drug Trials Exposed: How Statistical Flaws Skewed Results
In this week’s Journal of the American Medical Association (JAMA), researchers exposed a critical flaw in how Alzheimer’s disease (AD) drug trials measure success—specifically, a statistical method that may inflate ... Read More